“The opportunity to acquire this fermentation equipment, at this cost, is a game changer for Ayana Bio’s ability to perform consistent and cost-effective pilot scale development on plant cell lines,” says CEO Frank Jaksch.
The deal is part of xFarm’s long-term strategy to build what it calls “the data layer of global agriculture.”
Subscribe to the industry’s top headlines from the pages of AgFunderNews that week, as well as a roundup of global media coverage, a list of job openings in the sector, and alerts about our latest research reports.
By clicking Sign Up you’re confirming that you agree with our Terms and Conditions.
Sign up for our weekly newsletter.
